Literature DB >> 32187391

Meta-Analysis of Efficacy of Rhubarb Combined With Early Enteral Nutrition for the Treatment of Severe Acute Pancreatitis.

Xinrong Chen1, Kun Yang2, Guanda Jing1, Jie Yang2, Ka Li1.   

Abstract

BACKGROUND: Whether to provide rhubarb combined with early enteral nutrition (rhubarb/EEN) to patients with severe acute pancreatitis (SAP) remains controversial. This study aimed to systematically explore the efficacy and safety of rhubarb/EEN in SAP patients.
METHODS: We performed searches in EMBASE, PubMed, Medline, Cochrane Library, Chinese Biomedicine Literature Database (SinoMed), Chinese Scientific Journal Database (VIP), Chinese National Knowledge Infrastructure (CNKI), and Wanfang database to identify relevant literature comparing rhubarb/EEN with EEN for SAP.
RESULTS: Eleven randomized controlled trials (724 patients) were included. Meta-analysis showed significantly shorter length of hospital stay (days) (mean difference [MD], -4.49; 95% CI, -6.09 to -2.90; P < .00001), shorter length of intensive care unit stay (days) (MD, -2.82; 95% CI, -4.00 to -1.64; P < .00001), shorter length of severe abdominal pain (days) (MD, -2.20; 95% CI, -2.50 to -1.90; P < .00001), shorter length of abdominal distention (days) (MD, -2.31; 95% CI, -2.84 to -1.78; P < .00001), shorter length of abnormal bowel sounds (days) (MD, -0.98; 95% CI, -1.12 to -0.88; P < .00001), less hospitalization expenditure ($1422.75/¥ 10,000) (MD, -1.40; 95% CI, -1.23 to -0.73; P < .00001), and smaller Acute Physiology and Chronic Health Evaluation II scores (points) (MD, -2.18; 95% CI, -2.81 to -1.56; P < .00001) in the rhubarb/EEN group than in the EEN group. Compared with EEN, rhubarb/EEN group had lower levels of white blood cells (109 /L) (MD, -2.77; 95% CI, -3.80 to -1.74; P < .00001), C-reactive protein (mg/L) (MD, -10.71; 95% CI, -13.40 to -8.02; P < .00001), and interleukin-6 (ng/L) (MD, -8.02; 95% CI, -11.38 to -4.65; P < .00001). However, there were no significant differences (P > .05) between the 2 groups in terms of mortality rate (%) (P = .40), infection rate (%) (P = .28), and incidence of multiple organ dysfunction syndrome (%) (P = .09), but the overall effective rate was higher in the rhubarb/EEN group (MD, 2.57; 95% CI, 1.22 to ≈5.42; P = .01).
CONCLUSIONS: Combination of EEN and rhubarb may improve the gastrointestinal function, inhibit systemic inflammation and disease severity, and enhance the efficacy of enteral nutrition, leading to better therapeutic effectiveness in SAP patients.
© 2020 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  enteral nutrition; meta-analysis; rhubarb; severe acute pancreatitis

Mesh:

Year:  2020        PMID: 32187391     DOI: 10.1002/jpen.1789

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  4 in total

Review 1.  Effects of Anthraquinones on Immune Responses and Inflammatory Diseases.

Authors:  Dandan Xin; Huhu Li; Shiyue Zhou; Hao Zhong; Weiling Pu
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

2.  Exploration of the Curative Effect of Early Enteral Nutrition Nursing on Patients with Severe Acute Pancreatitis and the Improvement of Patients' Mental Health and Inflammation Level.

Authors:  Qigui Xiao; Lan Lang; Zhenhua Ma; Yulin Zhang; Kedong Xu
Journal:  J Healthc Eng       Date:  2021-09-11       Impact factor: 2.682

3.  Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis.

Authors:  Wenhua He; Peng Chen; Yupeng Lei; Liang Xia; Pi Liu; Yong Zhu; Hao Zeng; Yao Wu; Huajing Ke; Xin Huang; Wenhao Cai; Xin Sun; Wei Huang; Robert Sutton; Yin Zhu; Nonghua Lu
Journal:  Crit Care       Date:  2022-03-03       Impact factor: 9.097

Review 4.  Emodin-Mediated Treatment of Acute Kidney Injury.

Authors:  Yu Liu; Mingquan Li; LaiKuan Teh; Liangbin Zhao; Naijing Ye; Ling Wu; Lihua Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.